Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.

In studies examining potential interactions between ganciclovir (GCV) and either zidovudine (AZT) or didanosine (DDI) in H9 cells, GCV was found to consistently reduce the anti-human immunodeficiency virus type 1 potency of both AZT and DDI. In the presence of GCV, the 50% effective doses of AZT and...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Medina, D J, Hsiung, G D, Mellors, J W
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1992
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510405/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.5.1127
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!